Found: 21
Select item for more details and to access through your institution.
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2006, v. 21, n. 1, p. 13, doi. 10.1002/hup.741
- By:
- Publication type:
- Article
Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial.
- Published in:
- Journal of Asthma & Allergy, 2011, v. 4, p. 27, doi. 10.2147/JAA.S18265
- By:
- Publication type:
- Article
Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.
- Published in:
- Dermatology & Therapy, 2015, v. 5, n. 4, p. 217, doi. 10.1007/s13555-015-0089-y
- By:
- Publication type:
- Article
Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 7, p. 663, doi. 10.1007/s00228-011-1004-9
- By:
- Publication type:
- Article
New transcriptome and clinical findings of platelet‐activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1284, doi. 10.1002/biof.1880
- By:
- Publication type:
- Article
Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 1, p. 56, doi. 10.2340/00015555-2150
- By:
- Publication type:
- Article
Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 6, p. 663, doi. 10.1111/j.1365-2125.2010.03648.x
- By:
- Publication type:
- Article
No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a ‘thorough QT/QTc study’ performed according to ICH guidelines.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 4, p. 401, doi. 10.1111/j.1365-2125.2009.03599.x
- By:
- Publication type:
- Article
Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study.
- Published in:
- Journal of Asthma & Allergy, 2018, v. 11, p. 225, doi. 10.2147/JAA.S164632
- By:
- Publication type:
- Article
Population pharmacokinetic modelling of rupatadine solution in 6–11 year olds and optimisation of the experimental design in younger children.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176091
- By:
- Publication type:
- Article
Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163020
- By:
- Publication type:
- Article
Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study.
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 115, doi. 10.2147/CPAA.S312911
- By:
- Publication type:
- Article
Central and Peripheral Evaluation of Rupatadine, a New Antihistamine/Platelet-Activating Factor Antagonist, at Different Doses in Healthy Volunteers.
- Published in:
- Neuropsychobiology, 2004, v. 50, n. 4, p. 311, doi. 10.1159/000080959
- By:
- Publication type:
- Article
Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7357, doi. 10.3390/jcm12237357
- By:
- Publication type:
- Article
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
- Published in:
- Pediatric Allergy & Immunology, 2016, v. 27, n. 1, p. 55, doi. 10.1111/pai.12460
- By:
- Publication type:
- Article
Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
- Published in:
- Pediatric Allergy & Immunology, 2013, v. 24, n. 2, p. 144, doi. 10.1111/pai.12036
- By:
- Publication type:
- Article
Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis.
- Published in:
- Clinical & Translational Allergy, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13601-019-0293-4
- By:
- Publication type:
- Article
The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification.
- Published in:
- Rhinology, 2012, v. 50, n. 1, p. 33, doi. 10.4193/rhino11.071
- By:
- Publication type:
- Article
Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2020, v. 16, n. 1, p. 1, doi. 10.1186/s13223-020-00425-1
- By:
- Publication type:
- Article